Yayın:
Assessment and comparison of acute cardiac toxicity during high-dose cyclophosphamide and high-dose etoposide stem cell mobilization regimens with N-terminal pro-B-type natriuretic peptide

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGülbaş, Zafer
dc.contributor.authorCengiz Bal
dc.contributor.authorZafer Gülbaş
dc.contributor.orcid0000-0002-1553-2902
dc.contributor.orcid0000-0002-4709-0627
dc.date.accessioned2025-11-13T10:34:54Z
dc.date.issued2013-12-08
dc.identifier.doihttps://doi.org/10.1016/j.transci.2013.12.001
dc.identifier.endpage52
dc.identifier.issn1473-0502
dc.identifier.issue1
dc.identifier.openalexW1971222181
dc.identifier.startpage46
dc.identifier.urihttps://hdl.handle.net/11421/4606
dc.identifier.urihttps://doi.org/10.1016/j.transci.2013.12.001
dc.identifier.volume50
dc.language.isoen
dc.relation.ispartofTransfusion and Apheresis Science
dc.rightsrestrictedAccess
dc.subjectMedicine
dc.subjectCyclophosphamide
dc.subjectNatriuretic peptide
dc.subjectInternal medicine
dc.subjectEtoposide
dc.subjectHeart failure
dc.subjectBiomarker
dc.subjectToxicity
dc.subjectCardiac toxicity
dc.subjectCardiac function curve
dc.subjectBrain natriuretic peptide
dc.subjectCardiology
dc.subjectUrology
dc.subjectChemotherapy
dc.subjectGastroenterology
dc.subjectChemistry
dc.subject.sdg3
dc.titleAssessment and comparison of acute cardiac toxicity during high-dose cyclophosphamide and high-dose etoposide stem cell mobilization regimens with N-terminal pro-B-type natriuretic peptide
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5058571002

Dosyalar

Koleksiyonlar

Publications